Preparation and appraisal of self-assembled valsartan-loaded amalgamated Pluronic F127/Tween 80 polymeric micelles: Boosted cardioprotection via regulation of Mhrt/Nrf2 and Trx1 pathways in cisplatin-induced cardiotoxicity

References

• Bissessor N, White H. Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Vasc Health Risk Manag. 2007;3:425.
   PubMedGoogle Scholar
• Hadi NR, Al-Amran FG, Hussien YA, et al. The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury. cejoi. 2015;40:159.
   Google Scholar
• Nagarajan N, Oka S, Sadoshima J. Modulation of signaling mechanisms in the heart by thioredoxin 1. Free Radic Biol Med. 2017;109:125–131.
   PubMed Web of Science ®Google Scholar
• Medarević D, Cvijić S, Dobričić V, et al. Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: in vitro-in silico approach. Eur J Pharm Sci. 2018;124:188–198.
   PubMed Web of Science ®Google Scholar
• Biswas N. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan. Eur J Pharm Sci. 2017;99:152–160.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang W, Gao Y, et al. Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs. Drug Deliv Transl Res. 2017;7:100–110.
   PubMed Web of Science ®Google Scholar
• Biswas N, Kuotsu K. Chronotherapeutically modulated pulsatile system of valsartan nanocrystals – an in vitro and in vivo evaluation. AAPS Pharm Sci Tech. 2017;18:349–357.
   PubMed Web of Science ®Google Scholar
• Vuppalapati L, Cherukuri S, Neeli V, et al. Application of central composite design in optimization of valsartan nanosuspension to enhance its solubility and stability. CDD. 2016;13:143–157.
   PubMed Web of Science ®Google Scholar
• Chiappetta DA, Sosnik A. Poly (ethylene oxide)–poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66:303–317.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shi Y, Chen Y, et al. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. 2011;32:2894–2906.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, et al. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709–2728.
   PubMed Web of Science ®Google Scholar
• Parmar A, Singh K, Bahadur A, et al. Interaction and solubilization of some phenolic antioxidants in Pluronic® micelles. Colloids Surf B Biointerfaces. 2011;86:319–326.
   PubMed Web of Science ®Google Scholar
• Butt AM, Amin MCIM, Katas H, et al. In vitro characterization of Pluronic F127 and D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles as nanocarriers for targeted anticancer-drug delivery. J Nanomater. 2012;2012:1.
   Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces. 2012;97:101–108.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee J, Verma G, Aswal V, et al. Tween 80-sodium deoxycholate mixed micelles: structural characterization and application in doxorubicin delivery. J Phys Chem B. 2010;114:16414–16421.
   PubMed Web of Science ®Google Scholar
• Liang H, Yang Q, Deng L, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm. 2011;37:597–605.
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release. 2001;74:47–61.
   PubMed Web of Science ®Google Scholar
• El-Dahmy RM, Elsayed I, Elshafeey AH, et al. Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization. Int J Pharm. 2014;477:39–46.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, et al. Paclitaxel-loaded pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376:176–185.
   PubMed Web of Science ®Google Scholar
• Dou J, Zhang H, Liu X, et al. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration. Colloids Surf B: Biointerfaces. 2014;114:20–27.
   PubMed Web of Science ®Google Scholar
• Xia H-J, Zhang Z-h, Jin X, et al. A novel drug–phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo. Int J Nanomed. 2013;8:545.
   PubMed Web of Science ®Google Scholar
• Aboud HM, Hassan AH, Ali AA, et al. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Deliver. 2018;25:1328–1339.
   PubMed Web of Science ®Google Scholar
• Patil S, Choudhary B, Rathore A, et al. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Phytomedicine. 2015;22:1103–1111.
   PubMed Web of Science ®Google Scholar
• Mahmoud MO, Aboud HM, Hassan AH, et al. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release. 2017;254:10–22.
   PubMed Web of Science ®Google Scholar
• Lee SC, Kim C, Kwon IC, et al. Polymeric micelles of poly (2-ethyl-2-oxazoline)-block-poly (ε-caprolactone) copolymer as a carrier for paclitaxel. J Control Release. 2003;89:437–446.
   PubMed Web of Science ®Google Scholar
• Causse J, Lagerge S, De Menorval L-C, et al. Micellar solubilization of tributylphosphate in aqueous solutions of Pluronic block copolymers. Part I. Effect of the copolymer structure and temperature on the phase behavior. J Colloid Interface Sci. 2006;300:713–723.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Fan Y, et al. Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett. 2011;6:275.
   PubMed Web of Science ®Google Scholar
• Akashiba A, Ono H, Ono Y, et al. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats. J Cardiol. 2008;52:239–246.
   PubMed Web of Science ®Google Scholar
• Li DX, Yan YD, Oh DH, et al. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer. Drug Deliver. 2010;17:322–329.
   PubMed Web of Science ®Google Scholar
• El-Awady E-SE, Moustafa YM, Abo-Elmatty DM, et al. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol. 2011;650:335–341.
   PubMed Web of Science ®Google Scholar
• Watson LE, Sheth M, Denyer RF, et al. Baseline echocardiographic values for adult male rats. J Am Soc Echocardiogr. 2004;17:161–167.
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–191.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Theory and practice of histological techniques. Elsevier Health Sci. 2008.
   Google Scholar
• Gaucher G, Dufresne M-H, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release. 2005;109:169–188.
   PubMed Web of Science ®Google Scholar
• Lee ES, Oh YT, Youn YS, et al. Binary mixing of micelles using Pluronics for a nano-sized drug delivery system. Colloids Surf B: Biointerfaces. 2011;82:190–195.
   PubMed Web of Science ®Google Scholar
• Chen L, Sha X, Jiang X, et al. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. Int J Nanomed. 2013;8:73.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang J, Sun E, et al. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers. Drug Deliver. 2016;23:3248–3256.
   PubMed Web of Science ®Google Scholar
• Dahmani FZ, Yang H, Zhou J, et al. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci. 2012;47:179–189.
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Eedara BB, Jukanti R, et al. A Gelucire 44/14 and labrasol based solid self emulsifying drug delivery system: formulation and evaluation. J Pharm Investig. 2013;43:185–196.
   Google Scholar
• Pradhan R, Kim SY, Yong CS, et al. Preparation and characterization of spray-dried valsartan-loaded Eudragit® E PO solid dispersion microparticles. Asian J Pharm Sci. 2016;11:744–750.
   Web of Science ®Google Scholar
• Kulthe S, Inamdar N, Choudhari Y, et al. Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery. Colloids Surf B: Biointerfaces. 2011;88:691–696.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Tadros MI. Brain targeting of olanzapine via intranasal delivery of core–shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies. Int J Pharm. 2013;452:300–310.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Ali AA, Aboud HM, et al. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. DDDT. 2016;10:4031.
   PubMed Web of Science ®Google Scholar
• Yuan H, Lu L-J, Du Y-Z, et al. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption. Mol Pharm. 2011;8:225–238.
   PubMed Web of Science ®Google Scholar
• Guan M, Zhu Q-L, Liu Y, et al. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers. Int J Nanomed. 2012;7:1921.
   PubMed Web of Science ®Google Scholar
• Luo L, Tam J, Maysinger D, et al. Cellular internalization of poly (ethylene oxide)-b-poly (ε-caprolactone) diblock copolymer micelles. Bioconjugate Chem. 2002;13:1259–1265.
   PubMed Web of Science ®Google Scholar
• Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm. 2013;453:198–214.
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378.
   PubMed Web of Science ®Google Scholar
• Zablocki D, Sadoshima J. Angiotensin II and oxidative stress in the failing heart. Antioxidants Redox Signal. 2013;19:1095–1109.
   PubMed Web of Science ®Google Scholar
• Toko H, Oka T, Zou Y, et al. Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Hypertens Res. 2002;25:597–603.
   PubMed Web of Science ®Google Scholar
• Ma Q, Sun H, Che E, et al. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state. Int J Pharm. 2013;441:75–81.
   PubMed Web of Science ®Google Scholar
• Abdellatief SA, Galal AA, Farouk SM, et al. Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother. 2017;86:482–491.
   PubMed Web of Science ®Google Scholar
• Goyal S, Bharti S, Sahoo KC, et al. Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. Cardiovasc Toxicol. 2011;11:148–156.
   PubMed Web of Science ®Google Scholar
• Sui X, Wei H, Wang D. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF‐β1 and HIF‐1α in Ang II‐mediated fibrosis after myocardial infarction. J Cell Mol Med. 2015;19:1773–1782.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yi L-h, Meng G-y, et al. Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways. Free Radical Res. 2017;51:449–459.
   PubMed Web of Science ®Google Scholar
• Qian P, Yan LJ, Li YQ, et al. Cyanidin ameliorates cisplatin-induced cardiotoxicity via inhibition of ROS-mediated apoptosis. Exp Ther Med. 2018;15:1959–1965.
   PubMed Web of Science ®Google Scholar
• Imran M, Hassan MQ, Akhtar MS, et al. Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats. Clin Exp Hyperten. 2019;41:62–69.
   PubMed Web of Science ®Google Scholar
• Wozniak K, Czechowska A, Blasiak J. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571. Chem Biol Interact. 2004;147:309–318.
   PubMed Web of Science ®Google Scholar
• Santos N, Catao C, Martins N, et al. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol. 2007;81:495–504.
   PubMed Web of Science ®Google Scholar
• Raeisi S, Ghorbanihaghjo A, Argani H, et al. The effects of valsartan on renal glutathione peroxidase expression in alleviation of cyclosporine nephrotoxicity in rats. BioImpacts: BI. 2016;6:119.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao C, Meng M, et al. Long noncoding RNA MHRT protects cardiomyocytes against H2O2-induced apoptosis. Biomol Therapeutics. 2016;24:19.
   PubMed Web of Science ®Google Scholar
• Li H-Q, Wu Y-B, Yin C-S, et al. Obestatin attenuated doxorubicin-induced cardiomyopathy via enhancing long noncoding Mhrt RNA expression. Biomed Pharm. 2016;81:474–481.
   PubMed Web of Science ®Google Scholar
• Dammeyer P, Hellberg V, Wallin I, et al. Cisplatin and oxaliplatin are toxic to cochlear outer hair cells and both target thioredoxin reductase in organ of Corti cultures. Acta Oto-laryngologica. 2014;134:448–454.
   PubMed Web of Science ®Google Scholar
• Hellberg V, Wallin I, Eriksson S, et al. Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity. J Natl Cancer Inst. 2009;101:37–47.
   PubMedGoogle Scholar
• Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun. 2010;396:120–124.
   PubMed Web of Science ®Google Scholar
• Ago T, Yeh I, Yamamoto M, et al. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal. 2006;8:1635–1650.
   PubMed Web of Science ®Google Scholar
• Kylarova S, Kosek D, Petrvalska O, et al. Cysteine residues mediate high-affinity binding of thioredoxin to ASK1. FEBS J. 2016;283:3821–3838.
   PubMed Web of Science ®Google Scholar
• Nadeau PJ, Charette SJ, Landry J. REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell. 2009;20:3628–3637.
   PubMed Web of Science ®Google Scholar
• Izumiya Y, Kim S, Izumi Y, et al. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II–induced cardiac hypertrophy and remodeling. Circ Res. 2003;93:874–883.
   PubMed Web of Science ®Google Scholar
• Qi Z, Li Z, Li W, et al. Pseudoginsengenin DQ exhibits therapeutic effects in cisplatin-induced acute kidney injury via Sirt1/NF-κB and caspase signaling pathway without compromising its antitumor activity in mice. Molecules. 2018;23:3038.
   PubMed Web of Science ®Google Scholar
• Koh JS, Yi C-O, Ahn J-W, et al. Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice. Free Radical Biol Med. 2015;89:54–61.
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29:1727–1745.
   PubMed Web of Science ®Google Scholar
• Ha YM, Park EJ, Kang YJ, et al. Valsartan independent of AT 1 receptor inhibits tissue factor, TLR‐2 and‐4 expression by regulation of Egr‐1 through activation of AMPK in diabetic conditions. J Cell Mol Med. 2014;18:2031–2043.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang L, He S, et al. Nitric oxide synthesis-promoting effects of valsartan in human umbilical vein endothelial cells via the Akt/adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway. Bosn J Basic Med Sci. 2017;17:132.
   PubMed Web of Science ®Google Scholar
• Shao D, Oka S-I, Liu T, et al. A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab. 2014;19:232–245.
   PubMed Web of Science ®Google Scholar
• Joo MS, Kim WD, Lee KY, et al. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol. 2016;36:1931–1942.
   PubMed Web of Science ®Google Scholar
• Liu MH, Lin XL, Guo DM, et al. Resveratrol protects cardiomyocytes from doxorubicin‑induced apoptosis through the AMPK/P53 pathway. Mol Med Rep. 2016;13:1281–1286.
   PubMed Web of Science ®Google Scholar